Author
Listed:
- Angela Castoldi
(Max Planck Institute of Epigenetics and Immunobiology)
- Lauar B. Monteiro
(Max Planck Institute of Epigenetics and Immunobiology
University of Campinas)
- Nikki van Teijlingen Bakker
(Max Planck Institute of Epigenetics and Immunobiology
University of Freiburg)
- David E. Sanin
(Max Planck Institute of Epigenetics and Immunobiology)
- Nisha Rana
(Max Planck Institute of Epigenetics and Immunobiology)
- Mauro Corrado
(Max Planck Institute of Epigenetics and Immunobiology)
- Alanna M. Cameron
(Max Planck Institute of Epigenetics and Immunobiology)
- Fabian Hässler
(Max Planck Institute of Epigenetics and Immunobiology)
- Mai Matsushita
(Max Planck Institute of Epigenetics and Immunobiology)
- George Caputa
(Max Planck Institute of Epigenetics and Immunobiology)
- Ramon I. Klein Geltink
(Max Planck Institute of Epigenetics and Immunobiology)
- Jörg Büscher
(Max Planck Institute of Epigenetics and Immunobiology)
- Joy Edwards-Hicks
(Max Planck Institute of Epigenetics and Immunobiology)
- Erika L. Pearce
(Max Planck Institute of Epigenetics and Immunobiology)
- Edward J. Pearce
(Max Planck Institute of Epigenetics and Immunobiology
University of Freiburg)
Abstract
Foamy macrophages, which have prominent lipid droplets (LDs), are found in a variety of disease states. Toll-like receptor agonists drive triacylglycerol (TG)-rich LD development in macrophages. Here we explore the basis and significance of this process. Our findings indicate that LD development is the result of metabolic commitment to TG synthesis on a background of decreased fatty acid oxidation. TG synthesis is essential for optimal inflammatory macrophage activation as its inhibition, which prevents LD development, has marked effects on the production of inflammatory mediators, including IL-1β, IL-6 and PGE2, and on phagocytic capacity. The failure of inflammatory macrophages to make PGE2 when TG-synthesis is inhibited is critical for this phenotype, as addition of exogenous PGE2 is able to reverse the anti-inflammatory effects of TG synthesis inhibition. These findings place LDs in a position of central importance in inflammatory macrophage activation.
Suggested Citation
Angela Castoldi & Lauar B. Monteiro & Nikki van Teijlingen Bakker & David E. Sanin & Nisha Rana & Mauro Corrado & Alanna M. Cameron & Fabian Hässler & Mai Matsushita & George Caputa & Ramon I. Klein G, 2020.
"Triacylglycerol synthesis enhances macrophage inflammatory function,"
Nature Communications, Nature, vol. 11(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-17881-3
DOI: 10.1038/s41467-020-17881-3
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-17881-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.